Distinct Changes of BTLA and HVEM Expressions in Circulating CD4+ and CD8+ T Cells in Hepatocellular Carcinoma Patients
BTLA/HVEM (B and T lymphocyte attenuator/herpes virus entry mediator) pathways play a critical role in T cell suppression in tumor. However, its dynamic changes in different T cell subsets in peripheral blood and their clinical significance are largely unclear in cancer patients. In the current stud...
Saved in:
| Main Authors: | Jiayu Liu, Jiaqian Li, Min He, Geng-Lin Zhang, Qiyi Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2018/4561571 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-17-Expressing CD4+ and CD8+ T Lymphocytes in Human Toxoplasmosis
by: Jéssica Líver Alves Silva, et al.
Published: (2014-01-01) -
HLA‐DR⁺ Tumor Cells Show an Association with a Distinct Immune Microenvironment and CD8⁺ T‐Cell Exhaustion in HBV‐Associated Hepatocellular Carcinoma
by: Jun‐Qing Chang, et al.
Published: (2025-08-01) -
Single-cell analysis reveals XCL1+ CD8+ T cells as a therapeutic target in hepatocellular carcinoma
by: Guowei Li, et al.
Published: (2025-12-01) -
Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
by: Jinlin Miao, et al.
Published: (2015-01-01) -
Association of Absolute Lymphocyte Count and Circulating CD4+ and CD8+ T-Cells with Positive Clinical Outcome in Survivors of Cancer: An Observational Study
by: Suresh Rao, et al.
Published: (2019-07-01)